Pilot Study: Evaluating the Feasibility of Repetitive Transcranial Magnetic Stimulation Treatment Delivered at Individual-based, SCC-determined Frequency in Subjects Suffering From Major Depressive Disorder
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Inventory of Depressive Symptoms- Self report
研究概览
简要总结
This study will analyze the feasibility, safety, and tolerability of administering repetitive Transcranial magnetic stimulation(TMS) at frequencies other than standard 10 Hz. This study will enroll 50 subjects who will undergo one quantitative electroencephalograph, one TMS procedure to determine the appropriate frequency and intensity for treatment, weekly mood/symptom assessments, and up to 30 TMS treatments. Subjects will be asked to participate for up to 6 weeks.
详细描述
The therapeutic benefit of repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of Major Depressive Disorder (MDD) is thought to depend upon engagement of brain functional networks (FNs). Engagement is dependent upon an interaction between the rTMS stimulation frequency and the preferred oscillatory frequency of the target network for that individual. We report here on a novel method to interrogate the left dorsolateral prefrontal cortex (DLPFC) treatment target to identify the optimal frequency for engagement of the frontoparietal control network (FCN) for each individual. 23 subjects with MDD were stimulated with 40 pulse rTMS trains at frequencies varying from 3-17 Hz at 0.2 Hz increments, plus a separate intermittent theta burst (iTBS) stimulation, for a total of 70 frequency interrogations. FN engagement was assessed using continuous high-density array TMS-EEG recordings and measurement of the change in the density of the spectral correlation coefficient (SCC) between left DLPFC and other brain areas following each interrogation. All subjects had one or more frequency bands that showed high SCC values across multiple FNs, regardless of the frequency of interrogation. Those subjects who showed clinical response to 10 Hz rTMS showed increases in SCCD over FCN connections across in response to 10 Hz interrogation, but not in response to interrogation in other bands. There was a strong association between the increase in SCCD in FCN and degree of improvement in depressive symptoms after both 2 and 6 weeks of treatment. These findings suggest that SCC density may be useful for identifying rTMS stimulation frequencies that are associated with therapeutic benefit in MDD. This study will examine the feasibility using these findings to determine if SCC-determined rTMS treatment can benefit subjects with Major Depressive Disorder.
INTRODUCTION AND RATIONALE
Repetitive Transcranial Magnetic Stimulation (rTMS) has been reported to relieve symptoms of Major Depressive Disorder (MDD) when administered at a number of different stimulation frequencies: 1, 5, 10, 15, 18, and 50 Hz (theta burst stimulation, or TBS) all have reported to provide clinical benefit. It is difficult to compare the efficacy of these different frequencies of stimulation because of differences in study design and limitations of sample size, but there is significant evidence of efficacy for each of these frequencies when applied to one or more stimulation targets.1 There have not been head-to-head studies to compare different stimulation frequencies in individual subjects to determine whether individuals have similar clinical responses to more than one frequency of stimulation.
One feature that is shared by all frequencies of rTMS is that while stimulation is ongoing, both neuronal spiking and ongoing oscillations are synchronized to the frequency of stimulation (Fröhlich and McCormick, 2010 ; Thut et al., 2011 ). This modulation of cerebral oscillatory activity is hypothesized to underlie the therapeutic effects of rTMS for MDD. , Entrainment of brain oscillations has been shown to modify brain activity in a variety of functional networks (FNs), with changes in oscillations associated with alterations in task performance, local oscillatory activity, connectivity patterns and in the case of motor networks, corticospinal coupling.
Different frequencies of rTMS stimulation have distinct effects on FN engagement and task performance. These differential effects are consistent with the fact that FNs have one or more preferred resonant frequencies that mediate connectivity both within and across networks (Hacker et al., 2017 , , , The effects of rTMS stimulation depends upon the interaction between the frequency of stimulation and the ongoing oscillatory activity of the target FN(s): the oscillatory pattern of the specific brain region being stimulated (as measured with electroencephalography [EEG]) is a major determinant of rTMS engagement with the associated FN(s)3, and the effects on network performance.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All subjects must be over between 18-65 years of age.
- •Must have confirmed diagnosis of severe Major Depressive Disorder (single or recurrent episode).
- •Failure to respond to a minimum of 4 trials of antidepressant medication
- •Failure to respond from at least two different agent classes
- •Accompanied by at least two evidence-based augmentation therapies (Benzodiazepines do not count).
- •Must have a trial of psychotherapy known to be effective in the treatment of MDD of an adequate frequency and duration.
- •Subjects are willing and able to adhere to the treatment schedule and required study visits
排除标准
- •Are mentally or legally incapacitated, unable to give informed consent
- •Have an infection or poor skin condition over the scalp where the device will be positioned
- •Have increased risk of seizure because of family history, stroke, or currently use medications that lead to increased risk for seizure
- •Diagnosis of acute or chronic psychotic symptoms or disorders (such as schizophrenia, schizophreniform or schizoaffective disorder) in the current depressive episode.
- •Neurological conditions that include epilepsy, cerebrovascular disease, dementia, increased intracranial pressure, having a history of repetitive or severe head trauma, or with primary or secondary tumors in the central nervous system.
- •Presence of an implanted magnetic-sensitive medical device located less than or equal to 30 centimeters from the transcranial magnetic stimulation magnetic coil or other implanted metal items, including but not limited to a cochlear implant, implanted cardioverter defibrillator, pacemaker, vagus nerve stimulator, or metal aneurysm clips or coils, staples, or stents.
- •(Note: Dental amalgam fillings are not affected by the magnetic field and are acceptable for use with transcranial magnetic stimulation
研究组 & 干预措施
SCC
Subjects will be treated according to their frequency response pattern which may show one or more distinct frequencies of stimulation that generated increased SCC
干预措施: Transcranial Magnetic Stimulation (Device)
结局指标
主要结局
Inventory of Depressive Symptoms- Self report
时间窗: Weekly
This survey is designed to assess the severity of depressive symptoms. The IDS assess all the criterion symptom domains designated by the American PsychiatryAssociation Diagnostic and Statistical Manual of Mental Disorders - 4th edition (DSM-IV) (APA1994) to diagnose a major depressive episode. These assessments can be used to screen fordepression, although they have been used predominantly as measures of symptom severity. The seven day period prior to assessment is the usual time frame for assessing symptom severity.
次要结局
未报告次要终点
研究者
Andrew F. Leuchter
Director of UCLA Neuromodulation
University of California, Los Angeles
